A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer (NSCLC)
8 locations incl. Orange
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All·Age: 18+
Code: NCT07140016·Phase 1·Recruiting